PBEvsGNMXETF Comparison
VS
Invesco Dynamic Biotechnology & Genome ETF (PBE) and Corgi Genomics & Precision Medicine ETF (GNMX) belong to the same industry segment: BioTech & Genomics. Both ETFs have the same top 3 sector exposures: and Healthcare. PBE is more expensive with a Total Expense Ratio (TER) of 0.58%, versus 0.35% for GNMX. Run a side-by-side ETF comparison of PBE and GNMX below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
PBE vs GNMX performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 07/28/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | PBE GNMX | +1.97%-4.25% | +16.35%n/a | +12.84%n/a | +41.84%n/a | +47.30%n/a | +23.78%n/a |
| Flows | PBE GNMX | +$5M- | +$6M- | +$2M- | -$17M- | -$51M- | -$45M- |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | PBE GNMX | +19.07%n/a | +18.93%n/a | +20.29%n/a | +22.48%n/a |
| Max drawdown | PBE GNMX | -4.30%n/a | -11.70%n/a | -22.21%n/a | -34.74%n/a |
| Max drawdown duration | PBE GNMX | 21dn/a | 166dn/a | 324dn/a | 1540dn/a |
Trading data
PBE | GNMX | |
Last sale 7/29/2026 at 1:30 PM | $91.13 | |
| Previous close 07/28/2026 | $91.74 | |
| Consolidated volume 07/28/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of June 30, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
GNMX
is actively managed and doesn’t replicate an indexPBE | GNMX | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 7/29/2026 at 1:30 PM
Live
Closed
PBE | GNMX | |
|---|---|---|
| Last price | $91.13 | – |
| 1D performance | -0.66% | – |
| AuM | $288.75 M | $1.64 M |
| E/R | 0.58% | 0.35% |
Characteristics
PBE | GNMX | |
|---|---|---|
| Management strategy | Passive | Active |
| Provider | Invesco | Corgi Funds |
| Benchmark | Dynamic Biotech & Genome Intellidex Index | - |
| N° of holdings | 30 | 57 |
| Asset class | Equities | - |
| Trailing 12m distribution yield | Join | Join |
| Inception date | June 23, 2005 | May 6, 2026 |
| ESG | No | No |
Advertisement
Exposure
Countries
PBE
USA
97.25%
Other
2.75%
GNMX
USA
89.37%
Other
10.63%
Sectors
PBE
Healthcare
100%
Other
-0%
GNMX
Healthcare
98.21%
Other
1.79%
Diversification
PBE
Total weight of top 15 holdings out of 15
60.29%
GNMX
Total weight of top 15 holdings out of 15
53.1%
Top 15 holdings
Data as of June 30, 2026
PBE
Vertex Pharmaceuticals, Inc.
5.12%
Biogen, Inc.
5.08%
Amgen, Inc.
4.84%
Royalty Pharma Plc
4.74%
Regeneron Pharmaceuticals, Inc.
4.53%
Alnylam Pharmaceuticals, Inc.
4.48%
Gilead Sciences, Inc.
4.34%
United Therapeutics Corp.
4.26%
Bio-Techne Corp.
3.67%
Veracyte, Inc.
3.39%
CareDx, Inc.
3.31%
Vericel Corp.
3.27%
Repligen Corp.
3.16%
PTC Therapeutics, Inc.
3.09%
Protagonist Therapeutics, Inc.
3.02%
GNMX
Thermo Fisher Scientific, Inc.
7.80%
Vertex Pharmaceuticals, Inc.
6.73%
Guardant Health, Inc.
3.85%
Illumina, Inc.
3.84%
Revolution Medicines, Inc.
3.83%
Alnylam Pharmaceuticals, Inc.
3.77%
Moderna, Inc.
3.71%
Incyte Corp.
3.09%
Genmab A/S
2.54%
Bio-Techne Corp.
2.50%
Ionis Pharmaceuticals, Inc.
2.49%
Krystal Biotech, Inc.
2.43%
BioMarin Pharmaceutical, Inc.
2.33%
Arrowhead Pharmaceuticals, Inc.
2.12%
uniQure NV
2.07%
Frequently asked questions about PBE and GNMX
Which ETF is bigger: PBE or GNMX?
As of July 28, 2026, PBE holds $288.75 M in assets under management (AUM), while GNMX manages $1.64 M.
What sectors do the PBE and GNMX ETFs invest in?
PBE leans toward sectors like Healthcare. Meanwhile, GNMX focuses on Healthcare.
What are the top holdings of the PBE ETF and GNMX ETF?
PBE top holdings include Vertex Pharmaceuticals, Inc., Biogen, Inc. and Amgen, Inc.. GNMX holds in its top three: Thermo Fisher Scientific, Inc., Vertex Pharmaceuticals, Inc. and Guardant Health, Inc..
Which ETF is more diversified: PBE or GNMX?
PBE holds 30 securities with 60.29% of its assets in the top 15. GNMX has 57 securities and a top 15 weight of 53.1%.
Advertisement
Advertisement
